Vaginal Microbiome Research Consortium for Africa

ConditionHealthy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorUniversity of Cape Town

About this trial

1. To characterise vaginal microbial community dynamics (bacterial and fungal) from different geographies in Africa to understand the microbial diversity that occurs in women with stable L. crispatus-dominant versus unstable vaginal microbiota. 2. To identify vaginal communities associated with low levels of inflammation in women from different geographies in Africa 3. To examine prevalence and diversity of HPV types circulating in the different geographies and their interaction with the vaginal microbiota 4. To create a biobank of stored samples that can be used in future studies and for the isolation of regionally representative bacterial strains.

Eligibility criteria

Qualifiers

Female at birth

Willing and able to provide informed consent for screening and cognitive ability to understand sampling procedures

Not pregnant

HIV negative on testing performed by study staff

Disqualifiers

Male at birth

Not willing to provide consent

Pregnant or actively trying to conceive/become pregnant in the next 10 weeks

Living with HIV or untreated STIs (CT, NG, TV) or bacterial vaginosis (Nugent > 3)

Trial design

Treatments tested in this trial

  • None - observational study only

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Cape Town

Lead sponsor

Desmond Tutu HIV Foundation

Collaborator

Kenya Medical Research Institute

Collaborator